Cargando…
Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency
Major depressive disorder (MDD) is a common psychiatric disorder with multifactorial aetiology and complex pathophysiology. Despite availability of various pharmacological and non-pharmacological therapeutic strategies, treatment resistant depression (TRD) remains a significant challenge with specif...
Autor principal: | Nikkheslat, Naghmeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609146/ https://www.ncbi.nlm.nih.gov/pubmed/34849492 http://dx.doi.org/10.1016/j.bbih.2021.100383 |
Ejemplares similares
-
Minocycline in Major Depressive Disorder: And overview with considerations on treatment-resistance and comparisons with other psychiatric disorders
por: Nettis, Maria Antonietta
Publicado: (2021) -
Targeting neurotransmitter-mediated inflammatory mechanisms of psychiatric drugs to mitigate the double burden of multimorbidity and polypharmacy
por: Matt, Stephanie M.
Publicado: (2021) -
Maternal immune activation as a risk factor for psychiatric illness in the context of the SARS-CoV-2 pandemic
por: Lins, Brittney
Publicado: (2021) -
Can (immune and other) gene expression help us to treat depression?
por: Mariani, Nicole
Publicado: (2021) -
Lost in translation. The quest for definitions of treatment-resistant depression with a focus on inflammation-related gene expression
por: Sforzini, Luca
Publicado: (2021)